Evidence map›Paper›PMID 25986063›Full record

ArticleMalaria journal2015

Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa.

R Matthew Chico, Stephanie Dellicour, Elaine Roman, Viviana Mangiaterra, Jane Coleman, Clara Menendez, Maud Majeres-Lugand, Jayne Webster, Jenny Hill

Abstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

R Matthew ChicoDepartment of Disease Control, London School of Tropical Medicine and Hygiene, London, UK. Matthew.Chico@lshtm.ac.uk.
Stephanie DellicourDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK. Stephanie.Dellicour@lstmed.ac.uk.
Elaine RomanMaternal and Child Health Integrated Program, Jhpiego, Baltimore, MD, USA. Elaine.Roman@jhpiego.org.
Viviana MangiaterraRMNCH and HSS Technical Advice & Partnerships Department, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Vernier, Geneva, Switzerland. Viviana.Mangiaterra@theglobalfund.org.
Jane ColemanMaternal and Child Health Integrated Program, Jhpiego, Baltimore, MD, USA. Jane.Coleman@jhpiego.org.
Clara MenendezISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. menendez@clinic.ub.es.
Maud Majeres-LugandAccess & Product Management, Medicine for Malaria Venture, Geneva, Switzerland. majeresm@mmv.org.
Jayne WebsterDepartment of Disease Control, London School of Tropical Medicine and Hygiene, London, UK. Jayne.Webster@lshtm.ac.uk.
Jenny HillDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK. Jenny.Hill@lstmed.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intermittent preventive treatment of malaria in pregnancy is a highly cost-effective intervention which significantly improves maternal and birth outcomes among mothers and their newborns who live in areas of moderate to high malaria transmission. However, coverage in sub-Saharan Africa remains unacceptably low, calling for urgent action to increase uptake dramatically and maximize its public health impact. The 'Global Call to Action' outlines priority actions that will pave the way to success in achieving national and international coverage targets. Immediate action is needed from national health institutions in malaria-endemic countries, the donor community, the research community, members of the pharmaceutical industry and private sector, along with technical partners at the global and local levels, to protect pregnant women and their babies from the preventable, adverse effects of malaria in pregnancy.

Indexed as

Tropical MedicineAfrica South of the SaharaAntimalarialsFemaleHumansInfantInfant, NewbornMalariaPregnancyPublic HealthAntimalarials

Identifiers

PMID25986063
PMCPMC4458013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.